4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-16-075795
Director acquired 93,124 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GLUCK FREDERICK W · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-08-09 | Exercise or conversion : show line 1 in the form | +31,767 | $1.13 | $36,021 | 179,558 | D |
| 2016-08-09 | Exercise or conversion : show line 2 in the form | +16,612 | $0.95 | $15,698 | 196,170 | D |
| 2016-08-09 | Exercise or conversion : show line 3 in the form | +27,606 | $1.45 | $39,998 | 223,776 | D |
| 2016-08-09 | Exercise or conversion : show line 4 in the form | +17,139 | $1.57 | $26,992 | 240,915 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-08-09 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −31,767 | 0 | D |
| 2016-08-09 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −16,612 | 0 | D |
| 2016-08-09 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −27,606 | 0 | D |
| 2016-08-09 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −17,139 | 0 | D |
Loading xslF345X03/doc1.xml…